• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜死亡相关基因铁氧化还原蛋白1在甲状腺乳头状癌中的分子功能验证及预后价值分析

Molecular function validation and prognostic value analysis of the cuproptosis-related gene ferredoxin 1 in papillary thyroid carcinoma.

作者信息

He Shiyue, Peng Wenzhong, Hu Xinyue, Chen Yong

机构信息

Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, China.

Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, China.

出版信息

Sci Rep. 2025 Jul 23;15(1):26845. doi: 10.1038/s41598-025-11151-2.

DOI:10.1038/s41598-025-11151-2
PMID:40702045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12287535/
Abstract

Cuproptosis, a copper-dependent distinct form of cell death, holds a critical role in tumor development. However, further investigation is needed to elucidate the impact of the cuproptosis signaling on thyroid cancer. In this study, comprehensive bioinformatics analyses with six independent cohorts and in vitro experiments were performed to explore the expression, prognostic significance, and molecular function of the cuproptosis key regulator FDX1 in papillary thyroid carcinoma (PTC). LASSO regression analyses were utilized to screen the optimal combination of cuproptosis-related genes for constructing a Cox proportional-hazards model, and the cuproptosis-related risk score (CRRS) was calculated to stratify PTC patients in prognosis. The algorithm of ESTIMATE and ssGSEA were used to investigate the tumor immune microenvironment. Our results showed FDX1 was significantly downregulated in PTC, and its lower expression was closely associated with tumor recurrence. Based on six selected cuproptosis-related genes a predictive prognosis model was established and CRRS displayed a good prediction accuracy. Overexpression of FDX1 could promote cell death and inhibit the viability of tumor cells. Additionally, CYCS played a hub role in the cuproptosis regulatory network and could be upregulated with the overexpression of FDX1. Our study suggests that CRRS can serve as a good prognosis indicator and may provide new insights into cuproptosis-targeted therapies in PTC.

摘要

铜死亡是一种依赖铜的独特细胞死亡形式,在肿瘤发展中起着关键作用。然而,需要进一步研究以阐明铜死亡信号传导对甲状腺癌的影响。在本研究中,我们进行了六项独立队列的综合生物信息学分析和体外实验,以探究铜死亡关键调节因子FDX1在甲状腺乳头状癌(PTC)中的表达、预后意义和分子功能。利用LASSO回归分析筛选铜死亡相关基因的最佳组合以构建Cox比例风险模型,并计算铜死亡相关风险评分(CRRS)对PTC患者进行预后分层。运用ESTIMATE和ssGSEA算法研究肿瘤免疫微环境。我们的结果显示,FDX1在PTC中显著下调,其低表达与肿瘤复发密切相关。基于六个选定的铜死亡相关基因建立了预测预后模型,CRRS显示出良好的预测准确性。FDX1的过表达可促进细胞死亡并抑制肿瘤细胞活力。此外,CYCS在铜死亡调节网络中起核心作用,并且可随FDX1的过表达而上调。我们的研究表明,CRRS可作为良好的预后指标,并可能为PTC中针对铜死亡的治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/d9c8e1b5d16d/41598_2025_11151_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/b1d75bd3b1d2/41598_2025_11151_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/bfcab52e0ea8/41598_2025_11151_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/502b53c80316/41598_2025_11151_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/5034d2ba16b0/41598_2025_11151_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/0a1376a4821a/41598_2025_11151_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/68582809d9af/41598_2025_11151_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/849f44617fbe/41598_2025_11151_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/d9c8e1b5d16d/41598_2025_11151_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/b1d75bd3b1d2/41598_2025_11151_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/bfcab52e0ea8/41598_2025_11151_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/502b53c80316/41598_2025_11151_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/5034d2ba16b0/41598_2025_11151_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/0a1376a4821a/41598_2025_11151_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/68582809d9af/41598_2025_11151_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/849f44617fbe/41598_2025_11151_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0c/12287535/d9c8e1b5d16d/41598_2025_11151_Fig8_HTML.jpg

相似文献

1
Molecular function validation and prognostic value analysis of the cuproptosis-related gene ferredoxin 1 in papillary thyroid carcinoma.铜死亡相关基因铁氧化还原蛋白1在甲状腺乳头状癌中的分子功能验证及预后价值分析
Sci Rep. 2025 Jul 23;15(1):26845. doi: 10.1038/s41598-025-11151-2.
2
Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.基于 WGCNA 的 5 基因铜死亡特征识别预测结肠腺癌预后
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241250285. doi: 10.1177/15330338241250285.
3
Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancer.甲状腺乳头状癌预后相关分期的单细胞RNA测序和多组学分析
Cancer Immunol Immunother. 2025 Jul 12;74(8):267. doi: 10.1007/s00262-025-04101-4.
4
Expression of WNT10A in papillary thyroid carcinoma and its effect on cell proliferation, invasion, and metastasis.WNT10A在甲状腺乳头状癌中的表达及其对细胞增殖、侵袭和转移的影响。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 28;50(3):402-415. doi: 10.11817/j.issn.1672-7347.2025.240237.
5
High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma.高GOLT1A表达导致甲状腺乳头状癌预后不良。
Sci Rep. 2025 Jul 1;15(1):20979. doi: 10.1038/s41598-025-05747-x.
6
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.基于生物信息学和实验验证的透明细胞肾细胞癌中铜死亡特征的构建。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17451-17466. doi: 10.1007/s00432-023-05259-z. Epub 2023 Oct 27.
7
Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population.基于多组学的中国人群甲状腺乳头状癌DNA甲基化表型特征分析
Thyroid. 2025 May 30. doi: 10.1089/thy.2024.0611.
8
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.头颈部鳞状细胞癌中与铜死亡相关的新型预后基因特征和免疫微环境。
J Cancer Res Clin Oncol. 2023 Jan;149(1):203-218. doi: 10.1007/s00432-022-04471-7. Epub 2022 Nov 14.
9
Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.鉴定甲状腺癌中关于预后和免疫景观的独特二硫键病分类,并提供治疗策略。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11157-11170. doi: 10.1007/s00432-023-05006-4. Epub 2023 Jun 22.
10
Cannabinoid Derived Product is a Potential Novel Therapeutic for Papillary Thyroid Carcinoma.大麻素衍生产品是甲状腺乳头状癌的一种潜在新型疗法。
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251332966. doi: 10.1177/15347354251332966. Epub 2025 Jul 24.

本文引用的文献

1
Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc-ODC1 nexus.HIGD1A的高表达通过c-Myc-ODC1轴调节多胺代谢来驱动肝细胞癌进展。
Cancer Metab. 2024 Feb 23;12(1):7. doi: 10.1186/s40170-024-00334-6.
2
SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.SPCS,一种基于衰老轴调节因子的新型分类系统揭示了肿瘤微环境的异质性并指导透明细胞肾细胞癌的一线治疗。
Clin Genitourin Cancer. 2024 Apr;22(2):497-513. doi: 10.1016/j.clgc.2024.01.005. Epub 2024 Jan 12.
3
Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt/β-catenin pathway.
FHL1的过表达通过抑制Wnt/β-连环蛋白通路来抑制甲状腺乳头状癌的增殖和进展。
Endocrine. 2024 Jul;85(1):238-249. doi: 10.1007/s12020-023-03675-2. Epub 2024 Jan 9.
4
METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation.METTL3 通过抑制铜死亡相关的 pri-miR-21-5p 的成熟来促进非小细胞肺癌的生长和转移。
Epigenomics. 2023 Dec;15(23):1237-1255. doi: 10.2217/epi-2023-0230. Epub 2023 Dec 21.
5
Lactylation of METTL16 promotes cuproptosis via mA-modification on FDX1 mRNA in gastric cancer.METTL16 的乳酰化通过 FDX1 mRNA 上的 mA 修饰促进胃癌中的铜死亡。
Nat Commun. 2023 Oct 20;14(1):6523. doi: 10.1038/s41467-023-42025-8.
6
The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma.靶向铜死亡在肾透明细胞癌治疗中的潜力。
Biomed Pharmacother. 2023 Nov;167:115522. doi: 10.1016/j.biopha.2023.115522. Epub 2023 Sep 25.
7
Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.铜死亡促进免疫激活但促进免疫逃逸,基于机器学习的铜死亡相关特征可用于预测脑胶质瘤的预后和免疫治疗反应。
CNS Neurosci Ther. 2024 Feb;30(2):e14380. doi: 10.1111/cns.14380. Epub 2023 Jul 28.
8
Procyanidin C1 inhibits tumor growth and metastasis in colon cancer via modulating miR-501-3p/HIGD1A axis.原花青素 C1 通过调控 miR-501-3p/HIGD1A 轴抑制结肠癌的生长和转移。
J Adv Res. 2024 Jun;60:215-231. doi: 10.1016/j.jare.2023.07.007. Epub 2023 Jul 20.
9
Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy.与铜死亡相关的基因特征以及颞叶癫痫中差异表达的验证和潜在靶向药物
Front Pharmacol. 2023 Jun 26;14:1033859. doi: 10.3389/fphar.2023.1033859. eCollection 2023.
10
A Novel Oncogenic Role of FDX1 in Human Melanoma Related to PD-L1 Immune Checkpoint.PD-L1 免疫检查点相关的人类黑色素瘤中 FDX1 的新型致癌作用。
Int J Mol Sci. 2023 May 24;24(11):9182. doi: 10.3390/ijms24119182.